A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Partner Assistance in Learning and Performing Skin Self-Examination
- Status
- COMPLETED
- Phase
- NA
Survey Study - Sensitivity Comparison Between MelaFind and Physician Group
- Status
- COMPLETED
- Phase
- N/A
A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
- Status
- COMPLETED
- Phase
- N/A
Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients
- Status
- WITHDRAWN
- Phase
- NA
Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- N/A
Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Neurotropic Melanoma of the Head and Neck
- Status
- COMPLETED
- Phase
- NA
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
SCRI Tissue Testing Registry
- Status
- TERMINATED
- Phase
- N/A
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)
- Status
- TERMINATED
- Phase
- PHASE2
Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2